Cargando…
Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update
Serum biomarkers of osteoarticular diseases have been in the limelight of current clinical research trends. Laboratory validation of defined and candidate biomarkers for both osteoarthritis and osteoporosis is of key importance for future decisional algorithms in the diagnosis, monitoring, and progn...
Autores principales: | Nagy, Előd Ernő, Nagy-Finna, Csilla, Popoviciu, Horațiu, Kovács, Béla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152733/ https://www.ncbi.nlm.nih.gov/pubmed/32308378 http://dx.doi.org/10.2147/CIA.S242288 |
Ejemplares similares
-
Inflammatory and Metabolic Signaling Interfaces of the Hypertrophic and Senescent Chondrocyte Phenotypes Associated with Osteoarthritis
por: Horváth, Emőke, et al.
Publicado: (2023) -
Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Interface in Osteoarthritis
por: Kovács, Béla, et al.
Publicado: (2019) -
Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results
por: Szabo, Timea Magdolna, et al.
Publicado: (2021) -
Measurement of Soluble Biomarkers by Flow Cytometry
por: Antal-Szalmás, Péter, et al.
Publicado: (2013) -
Neuroinflammation and microglia/macrophage phenotype modulate the molecular background of post-stroke depression: A literature review
por: Nagy, Előd Ernő, et al.
Publicado: (2020)